Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  neoantigen-based melanoma-poly-ICLC vaccine
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
CDX-1401 and Poly-ICLC Vaccine Therapy with or without CDX-301in Treating Patients with Stage IIB-IV Melanoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CITN-07-FLT3L, NCI-2014-00898, NCT02129075
Vaccine Therapy in Treating Patients with Stage IIIB-IV Melanoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 13-240, NCI-2014-00958, NCT01970358
Start Over